Valnemulin

Star0

DB19713ExperimentalSmall molecule

Valnemulin is a small molecule drug. Valnemulin has a monoisotopic molecular weight of 564.36 Da.

Mechanism: Pharmacologically active on 23S ribosomal RNA
Curator reviewed
Formula / weight: C₃₁H₅₂N₂O₅S · 564.83 g/mol (avg)

Resolves to

Compound

UNII2AHC415BQGCAS101312-92-9ChEMBLCHEMBL1688852

Clinical / RWD

RxNorm2604036

Structure

InChIKeyLLYYNOVSVPBRGV-MVNKZKPCSA-NSMILES[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CSC(C)(C)CNC(=O)[C@H](N)C(C)C

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Valnemulin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account